We are live on
!
Find out more
KXA
KPCB XII Associates Portfolio holdings
AUM
$738K
1-Year Est. Return
3.15%
This Fund
S&P 500
This Quarter
Est. Return
-16.73%
1 Year Est. Return
-3.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$137M
AUM Growth
–
Cap. Flow
+$152M
Cap. Flow
% of AUM
110.94%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CBLK
Carbon Black, Inc. Common Stock
CBLK
|
+$76M |
| 2 |
Inspire Medical Systems
INSP
|
+$74.7M |
| 3 |
AMRS
Amyris Inc.
AMRS
|
+$1.46M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 54.1% |
| 2 | Technology | 45.29% |
| 3 | Materials | 0.62% |
Similar funds
TA
LCM
ACP
FG
RCG
FWCM
MVUM
BCIM
KPCB XII Associates's Q4 2018 Portfolio in Review
Q4 2018 is the first quarter with a 13F filing on record for KPCB XII Associates, which disclosed 3 positions worth $137M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Carbon Black, Inc. Common Stock: 4,628,653 shares worth $62.1M.
By sector, the portfolio is most concentrated in Healthcare at 54% of assets, followed by Technology and Materials.
- KPCB XII Associates's largest Q4 2018 buy was Carbon Black, Inc. Common Stock: 4,628,653 shares worth $62.1M.
- KPCB XII Associates's ten largest holdings make up 100% of its $137M portfolio in Q4 2018.
- KPCB XII Associates disclosed 3 positions in Q4 2018, its first 13F filing on record.
Based on KPCB XII Associates's 13F filing for Q4 2018, filed 14 Feb 2019.